Present status and future aspects of gastric cancer-risk A, B, C, D gastritis screening (ABC screening)

一正, 三木

doi:10.7143/jhep.38.357

Cited by 1 publication

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It remains to be seen whether the ABC method, 39 , 75 , 76 , 82 ) which was introduced in 2007 and has been studied for only 3 years, is effective. Because 70% of the patients with gastric cancer have been found in group B, for which endoscopic examination would have been performed only once in 5 years by the conventional PG method, the ABC method is likely to detect PG-negative gastric cancer at an early stage.…”

Section: Ongoing Trial Of the Abc Methods In Tokyomentioning

confidence: 99%

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method"

Miki

2011

Proc. Jpn. Acad., Ser. B

Self Cite

229

259

View full text Add to dashboard Cite

The current status of screening for gastric cancer-risk (gastritis A, B, C, D) method using combined assay for serum anti-Helicobacter pylori (Hp) IgG antibody and serum pepsinogen (PG) levels, “ABC method”, was reviewed and the latest results of our ongoing trial are reported. It was performed using the following strategy: Subjects were classified into 1 of 4 risk groups based on the results of the two serologic tests, anti-Hp IgG antibody titers and the PG I and II levels: Group A [Hp(−)PG(−)], infection-free subjects; Group B [Hp(+)PG(−)], chronic atrophic gastritis (CAG) free or mild; Group C [Hp(+)PG(+)], CAG; Group D [Hp(−)PG(+)]), severe CAG with extensive intestinal metaplasia. Continuous endoscopic follow-up examinations are required to detect early stages of gastric cancer. Asymptomatic Group A, which accounts for 50–80% of all the subjects may be excluded from the secondary endoscopic examination, from the viewpoint of efficiency. Hp-infected subjects should be administered eradication treatment aimed at the prevention of gastric cancer.

show abstract

Section: Ongoing Trial Of the Abc Methods In Tokyomentioning

confidence: 99%